1,2-distearoylphosphatidylethanolamine

Known as: distearoyl-L-phosphatidylethanolamine, 1,2-dioctadecanoyl-sn-glycero-3-phosphoethanolamine, DSPE 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Phosphatidylethanolamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Using 915 nm laser excited Tm³+/Er³+/Ho³+- doped NaYbF4 upconversion nanoparticles for in vitro and deeper in vivo bioimaging without overheating irradiation.
Successful further development of superhigh-constrast upconversion (UC) bioimaging requires addressing the existing paradox: 980… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Nanoparticles evading the reticuloendothelial system: role of the supported bilayer.
We have previously shown that the PEGylated LPD (liposome-polycation-DNA) nanoparticles were highly efficient in delivering siRNA… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Site-specific delivery of drugs and therapeutics can significantly reduce drug toxicity and increase the therapeutic effect… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor.
We have developed a nanoparticle formulation [liposomes-protamine-hyaluronic acid nanoparticle (LPH-NP)] for systemically… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Selective gene inhibition by antisense oligodeoxynucleotide (AS-ODN) or by small interference RNA (siRNA) therapeutics promises… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.
Sterically stabilized micelles (SSM) composed of poly(ethylene glycol-2000)-grafted distearoylphosphatidylethanolamine (DSPE-PEG… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
Folic acid, attached to polyethyleneglycol-derivatized, distearoyl-phosphatidylethanolamine, was used to target in vitro… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Prolongation of the Circulation Time of Doxorubicin Encapsulated in Liposomes Containing a Polyethylene Glycol-Derivatized Phospholipid: Pharmacokinetic Studies in Rodents and Dogs
The pharmacokinetics of doxorubicin (DOX) encapsulated in liposomes containing polyethylene glycol-derivatized… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.
Novel synthetic lipid derivatives of poly(ethylene glycol) (PEG) have been synthesized and tested for their ability to decrease… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Liposomes for the sustained drug release in vivo.
New lipidic carriers suitable for the sustained drug release in vivo are presented. They consist of middle sized, compact… (More)
Is this relevant?